Multiple observations of increased levels of MCP-1/CCL2, MIP-1a/CCL3, MIP-1b/CCL4, and fractalkine/CX3CL1 in SLE support our findings [47,48,49]. This evidence concerns the gene CCL4 and systemic lupus erythematosus.